ATP2A3
Basic information
Region (hg38): 17:3923868-3964464
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATP2A3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 21 | 16 | 37 | |||
missense | 52 | 64 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 2 | 5 | |||
non coding | 3 | |||||
Total | 0 | 0 | 52 | 29 | 23 |
Variants in ATP2A3
This is a list of pathogenic ClinVar variants found in the ATP2A3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-3925403-T-C | ATP2A3-related disorder | Benign (Feb 22, 2019) | ||
17-3925408-T-C | ATP2A3-related disorder | Benign (Oct 18, 2019) | ||
17-3925441-T-C | not specified | Uncertain significance (Aug 01, 2024) | ||
17-3927972-G-A | ATP2A3-related disorder | Benign (Jul 31, 2018) | ||
17-3928687-A-G | not specified | Uncertain significance (Nov 28, 2023) | ||
17-3928749-C-T | not specified | Uncertain significance (Sep 11, 2024) | ||
17-3928753-C-T | not specified | Uncertain significance (Nov 14, 2024) | ||
17-3928785-C-T | ATP2A3-related disorder | Benign (Sep 24, 2019) | ||
17-3929420-G-A | not specified | Conflicting classifications of pathogenicity (Mar 25, 2024) | ||
17-3929439-C-T | ATP2A3-related disorder | Benign (Sep 24, 2019) | ||
17-3929440-G-A | not specified | Uncertain significance (Aug 17, 2021) | ||
17-3929442-G-A | ATP2A3-related disorder | Likely benign (Jun 12, 2019) | ||
17-3929444-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
17-3930308-G-A | not specified | Uncertain significance (Feb 08, 2023) | ||
17-3930325-A-G | not specified | Uncertain significance (May 03, 2023) | ||
17-3930370-T-C | not specified | Uncertain significance (Dec 01, 2022) | ||
17-3930371-C-T | ATP2A3-related disorder | Likely benign (May 10, 2022) | ||
17-3930377-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
17-3930386-C-T | ATP2A3-related disorder | Benign (Sep 24, 2019) | ||
17-3930403-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
17-3930413-C-T | not specified | Uncertain significance (Mar 21, 2023) | ||
17-3930414-G-T | ATP2A3-related disorder | Benign (Dec 11, 2017) | ||
17-3935209-T-C | not specified | Likely benign (Jan 10, 2022) | ||
17-3935273-G-A | ATP2A3-related disorder | Likely benign (Apr 25, 2019) | ||
17-3935277-A-C | not specified | Uncertain significance (Mar 07, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATP2A3 | protein_coding | protein_coding | ENST00000359983 | 23 | 40568 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.25e-9 | 1.00 | 125703 | 0 | 45 | 125748 | 0.000179 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.83 | 537 | 671 | 0.801 | 0.0000498 | 6711 |
Missense in Polyphen | 230 | 351.92 | 0.65356 | 3550 | ||
Synonymous | -2.53 | 352 | 297 | 1.19 | 0.0000244 | 2219 |
Loss of Function | 3.51 | 23 | 49.7 | 0.463 | 0.00000279 | 518 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000206 | 0.000206 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000191 | 0.000185 |
European (Non-Finnish) | 0.000257 | 0.000255 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000330 | 0.0000327 |
Other | 0.000498 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium. Transports calcium ions from the cytosol into the sarcoplasmic/endoplasmic reticulum lumen. Contributes to calcium sequestration involved in muscular excitation/contraction. {ECO:0000269|PubMed:11956212, ECO:0000269|PubMed:15028735}.;
- Pathway
- Alzheimer,s disease - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Celecoxib Pathway, Pharmacodynamics;Alzheimers Disease;Myometrial Relaxation and Contraction Pathways;Calcium Regulation in the Cardiac Cell;nfat and hypertrophy of the heart ;Ion channel transport;Purine metabolism;Ion homeostasis;Transport of small molecules;Cardiac conduction;Muscle contraction;Ion transport by P-type ATPases;Hemostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Platelet homeostasis
(Consensus)
Recessive Scores
- pRec
- 0.198
Intolerance Scores
- loftool
- 0.00675
- rvis_EVS
- -1.47
- rvis_percentile_EVS
- 3.74
Haploinsufficiency Scores
- pHI
- 0.129
- hipred
- Y
- hipred_score
- 0.744
- ghis
- 0.570
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.615
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Atp2a3
- Phenotype
- muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- calcium ion transport;cellular calcium ion homeostasis;ion transmembrane transport;calcium ion transmembrane transport;ATP hydrolysis coupled cation transmembrane transport;proton transmembrane transport;regulation of cardiac conduction
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane;sarcoplasmic reticulum;platelet dense tubular network membrane;nuclear membrane;sarcoplasmic reticulum membrane
- Molecular function
- calcium-transporting ATPase activity;ATP binding;proton-exporting ATPase activity, phosphorylative mechanism;metal ion binding